Ferriprox

Ferriprox is a brand name of deferiprone, approved by the FDA in the following formulation(s):

FERRIPROX (deferiprone - tablet; oral)

• 
  Manufacturer: APOPHARMA INC
  
  Approval date: October 14, 2011
  
  Strength(s): 500MG ^[RLD]

Has a generic version of Ferriprox been approved?

No. There is currently no therapeutically equivalent version of Ferriprox available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ferriprox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ferriprox.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 14, 2016 - NEW CHEMICAL ENTITY
  
  
  • October 14, 2018 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Ferriprox Consumer Information (Drugs.com)
• Ferriprox Consumer Information (Wolters Kluwer)
• Deferiprone Consumer Information (Wolters Kluwer)